Aradigm and CyDex, Development Collaboration Agreement for the treatment of asthma and chronic obstructive pulmonary diseases (COPD).

September 6, 2007 - Aradigm Corporation (OTCBB:ARDM) and CyDex, Inc. ("CyDex") have entered into a two-year Collaboration Agreement for the development and commercialization of combination products containing inhaled corticosteroids, anticholinergics and beta-2 agonists for the treatment of asthma and chronic obstructive pulmonary diseases (COPD)... Press Release -